drugset

drugset / Trial / NCT01054937

Single Dose Study With 4SC-203 in Healthy Volunteers

NCT01054937 ↗

Phase 1 Completed 60 enrolled 4SC AG

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate safety and tolerability of 4SC-203 after a single dose administration in healthy volunteers.

Timeline

Start: 2010-01
Primary completion: 2010-11
Completion: 2010-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	4SC-203	Small molecule	—	Intravenous

Indications